Lepu Medical Technology (Beijing) Co., Ltd.

SZSE:300003 Stock Report

Market Cap: CN¥20.7b

Lepu Medical Technology (Beijing) Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Fei Pu

Chief executive officer

CN¥792.0k

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownershipn/a
Management average tenure10.8yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Will Want To Turn Around Its Return Trends

Mar 25
Lepu Medical Technology (Beijing) (SZSE:300003) Will Want To Turn Around Its Return Trends

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Mar 08
Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Fewer Investors Than Expected Jumping On Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003)

Feb 17
Fewer Investors Than Expected Jumping On Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003)

Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Dec 03
Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Nov 15
Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28
Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Oct 18
Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

Sep 02
Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Aug 31
News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27
Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16
Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23
Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31
Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13
Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28
Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

CEO

Fei Pu (35 yo)

5.3yrs
Tenure
CN¥792,000
Compensation

Ms. Fei Pu is General Manager of Lepu Medical Technology (Beijing) Co. Ltd. Ms. Pu is Non Independent Director of Lepu Medical Technology (Beijing) Co. Ltd. from January 22, 2020.


Leadership Team

NamePositionTenureCompensationOwnership
Zhongjie Pu
Chairman & CTO17.4yrsno data12.37%
CN¥ 2.6b
Fei Pu
CEO & Non Independent Directorno dataCN¥792.00kno data
Yong Wang
Senior Deputy GM & CFO18.2yrsCN¥1.53m0.010%
CN¥ 2.2m
Weina Jiang
Secretary of the Board3.8yrsCN¥1.28mno data
Zhan Jiang Wei
Senior Deputy General Managerno dataCN¥1.36m0.011%
CN¥ 2.2m
Bing Feng Zhang
Deputy General Managerno dataCN¥1.36mno data
Xiaoying Feng
Deputy General Manager4.1yrsCN¥977.20k0.00040%
CN¥ 82.8k
10.8yrs
Average Tenure
50yo
Average Age

Experienced Management: 300003's management team is seasoned and experienced (10.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zhongjie Pu
Chairman & CTO17.4yrsno data12.37%
CN¥ 2.6b
Fei Pu
CEO & Non Independent Director5.3yrsCN¥792.00kno data
Yang Xu
Non Independent Director11.3yrsCN¥300.00kno data
Qian Chen
Employee Supervisor2.1yrsno datano data
Liang Gan
Independent Director5.3yrsCN¥300.00kno data
Xinglin Wang
Chairman of the Supervisory Board5.3yrsno datano data
Jun Wang
Non Employee Supervisor5.3yrsno datano data
Lihua Wang
Independent Director5.1yrsCN¥300.00kno data
Qihong Wang
Non-Independent Vice Chairman4.2yrsno datano data
Xin Qu
Independent Director2yrsCN¥300.00kno data
5.3yrs
Average Tenure
58yo
Average Age

Experienced Board: 300003's board of directors are considered experienced (5.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 22:43
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lepu Medical Technology (Beijing) Co., Ltd. is covered by 25 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Bo YuChina International Capital Corporation Limited